Systematic review: Malfunction of totally implantable venous access devices in cancer patients

Supportive Care in Cancer

Volumn 19, Issue 7, 2011, Pages 883-898

  Goossens, Godelieve Alice ^a,b   Stas, Marguerite ^a   Jérôme, Martine ^a   Moons, Philip ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adult; Catheterization; Catheters; Central venous; Functional outcomes; Indwelling; Neoplasms; Review

Indexed keywords

POLYURETHAN; SILICON;

CANCER PATIENT; CATHETER COMPLICATION; CATHETER MALFUNCTION; CATHETER OCCLUSION; HUMAN; INCIDENCE; INFORMATION PROCESSING; INTRAVASCULAR CATHETER; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; VASCULAR ACCESS DEVICE;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT FAILURE; HEMATOLOGY; HUMANS; INCIDENCE; MEDICAL ONCOLOGY; NEOPLASMS; RISK FACTORS;

EID: 80051587273     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1171-3     Document Type: Review

References (61)

1. Akahane A, Sone M, Ehara S, Kato K, Tanaka R, Nakasato T (2010) Subclavian vein versus arm vein for totally implantable central venous port for patients with head and neck cancer: a retrospective comparative analysis. Cardiovasc Intervent Radiol. doi:10.1007/s00270-010-0051-4
2. Araujo C, Silva JP, Antunes P, Fernandes JM, Dias C, Pereira H, Dias T, Fougo JL (2008) A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. Eur J Surg Oncol 34:222-226
3. Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204-1212 (Pubitemid 32861670)
4. Biffi R, De Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767-773 (Pubitemid 28394164)
5. Biffi R, Martinelli G, Pozzi S, Cinieri S, Cocorocchio E, Peccatori F, Ferrucci PF, Pistorio R, Andreoni B (1999) Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant 24:89-93 (Pubitemid 29346611)
6. Biffi R, Pittiruti M, Gillet JP, Fobe D, Hermanne JP, Pescio M, Gourlia A, Collet K, Battelli C, Cenciarelli S (2002) Valved central venous catheter connected to subcutaneous port: a multicenter phase IV study based on a cohort of 50 oncology patients. J Vasc Access 3:147-153 (Pubitemid 36336489)
7. Bodner LJ, Nosher JL, Patel KM, Siegel RL, Biswal R, Gribbin CE, Tokarz R (2000) Peripheral venous access ports: outcomes analysis in 109 patients. Cardiovasc Interv Radiol 23:187-193 (Pubitemid 30421898)
8. Brown DF, Muirhead MJ, Travis PM, Vire SR, Weller J, Hauer-Jensen M (1997) Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer 80:966-972 (Pubitemid 27360480)
9. Burbridge B, Krieger E, Stoneham G (2000) Arm placement of the cook titanium Petite Vital-Port: results of radiologic placement in 125 patients with cancer. Can Assoc Radiol J 51:163-169 (Pubitemid 30643944)
10. Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P (2005) Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 13:325-331 (Pubitemid 40674838)
11. Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722-727
12. Carre MC, Lopez Vega JM, Carles J, Lizon J, Villar A, Lera SA, Alastrue A, Rull M, Van der HC, Aguilo J (1994) Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM). J Surg Oncol 55:190-193 (Pubitemid 24096522)
13. Chang HM, Hsieh CB, Hsieh HF, Chen TW, Chen CJ, Chan DC, Yu JC, Liu YC, Shen KL (2006) An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. Eur J Surg Oncol 32:90-93 (Pubitemid 43103995)
14. Chen PT, Sung CS, Wang CC, Chan KH, Chang WK, Hsu WH (2007) Experience of anesthesiologists with percutaneous non-angiographic venous access. J Clin Anesth 19:609-615
15. Conessa C, Talfer S, Herve S, Chollet O, Poncet JL (2002) Cephalic vein access for implantable venous access devices. Technique and long-term follow-up. Rev Laryngol Otol Rhinol (Bord) 123:143-148 (Pubitemid 36090935)
16. Cunningham MJ, Collins MB, Kredentser DC, Malfetano JH (1996) Peripheral infusion ports for central venous access in patients with gynecologic malignancies. Gynecol Oncol 60:397-399 (Pubitemid 26077624)
17. de Gregorio MA, Miguelena JM, Fernandez JA, de Gregorio C, Tres A, Alfonso ER (1996) Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients. Eur Radiol 6:748-752 (Pubitemid 126464384)
18. Dede D, Akmangit I, Yildirim ZN, Sanverdi E, Sayin B (2008) Ultrasonography and fluoroscopy-guided insertion of chest ports. Eur J Surg Oncol 34:1340-1343
19. Deppe G, Kahn ML, Malviya VK, Malone JM Jr, Christensen CW (1996) Experience with the P.A.S.-PORT venous access device in patients with gynecologic malignancies. Gynecol Oncol 62:340-343 (Pubitemid 26322423)
20. Di Carlo I, Cordio S, La Greca G, Privitera G, Russello D, Puleo S, Latteri F (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050-1053 (Pubitemid 32982996)
21. Estes JM, Rocconi R, Straughn JM, Bhoola S, Leath CA, Alvarez RD, Kilgore LC, Huh WK (2003) Complications of indwelling venous access devices in patients with gynecologic malignancies. Gynecol Oncol 91:591-595 (Pubitemid 38388156)
22. Frank JL, Garb JL, Halla B, Reed WP Jr (2001) Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial. Surgery 129:547-551 (Pubitemid 32374985)
23. Gleeson NC, Fiorica JV, Mark JE, Pinelli DM, Hoffman MS, Roberts WS, Cavanagh D (1993) Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 51:372-376 (Pubitemid 24058614)
24. Goossens GA, Verbeeck G, Moons P, Sermeus W, De Wever I, Stas M (2008) Functional evaluation of conventional 'Celsite' venous ports versus 'Vortex' ports with a tangential outlet: a prospective randomised pilot study. Support Care Cancer 16:1367-1374
25. Groebli Y, Wutrich P, Safa M, Tschantz P, Callewaert G, Piguet D (1999) Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases. Panminerva Med 41:89-92
26. Hartkamp A, van Boxtel AJ, Zonnenberg BA, Witteveen PO (2000) Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57:215-223
27. Heibl C, Trommet V, Burgstaller S, Mayrbaeurl B, Baldinger C, Koplmuller R, Kuhr T, Wimmer L, Thaler J (2010) Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care (Engl) 19:676-681
28. Hoekstra A, Bassot V, Bertoglio S, Bobin JY, Delassus P, Egeli R, Khayat D, Ranchere JY, Santini J, Segol P (1993) Clinical evaluation of the CORDIS vascular access port systems: a multicenter study. Med Oncol Tumor Pharmacother 10:131-138 (Pubitemid 23290565)
29. Jan HC, Chou SJ, Chen TH, Lee CI, Chen TK, Lou MA (2010) Management and prevention of complications of subcutaneous intravenous infusion port. Surg Oncol doi:10.1016/j.suronc.2010.07.001
30. Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P, Backman L, Weitzberg E, Engervall P (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study. Support Care Cancer 12:99-105 (Pubitemid 38222495)
31. Labourey JL, Lacroix P, Genet D, Gobeaux F, Martin J, Venat-Bouvet L, Lavau-Denes S, Maubon A, Tubiana-Mathieu N (2004) Thrombotic complications of implanted central venous access devices: prospective evaluation. Bull Cancer 91:431-436 (Pubitemid 38758689)
32. Lemmers NW, Gels ME, Sleijfer DT, Plukker JT, van der Graaf WT, de Langen ZJ, Droste JH, Koops HS, Hoekstra HJ (1996) Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol 14:2916-2922 (Pubitemid 26371449)
33. Lenhart M, Chegini M, Gmeinwieser J, Manke C, Feuerbach S (1998) Radiologic implantation of central venous portal systems in the forearm. Rofo 169:189-194 (Pubitemid 28380708)
34. Lenhart M, Schatzler S, Manke C, Strotzer M, Seitz J, Gmeinwieser J, Volk M, Zorger N, Feuerbach S, Herold T, Paetzel C (2010) Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients. Rofo 182:20-28
35. Lersch C, Eckel F, Sader R, Paschalidis M, Zeilhofer F, Schulte-Frohlinde E, Theiss W (1999) Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy. Oncology 57:269-275
36. Marcy PY, Chamorey E, Amoretti N, Benezery K, Bensadoun RJ, Bozec A, Poissonnet G, Dassonville O, Rame M, Italiano A, Peyrade F, Brenac F, Gallard JC (2008) A comparison between distal and proximal port device insertion in head and neck cancer. Eur J Surg Oncol 34:1262-1269
37. Marcy PY, Magne N, Castadot P, Italiano A, Amoretti N, Bailet C, Bentolila F, Gallard JC (2007) Is radiologic placement of an arm port mandatory in oncology patients?: analysis of a large bi-institutional experience. Cancer 110:2331-2338 (Pubitemid 350100756)
38. McNulty NJ, Perrich KD, Silas AM, Linville RM, Forauer AR (2010) Implantable subcutaneous venous access devices: is port fixation necessary? A review of 534 cases. Cardiovasc Interv Radiol 33:751-755
39. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706-712 (Pubitemid 13091564)
40. Nishinari K, Wolosker N, Bernardi CV, Yazbek G (2010) Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices. J Vasc Access 11:17-22
41. Ozdemir NY, Abali H, Oksuzoglu B, Budakoglu B, Akmangit I, Zengin N (2009) It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting. Support Care Cancer 17:399-403
42. Pardo I, Rager EL, Bowling MW, Fajardo A, Clare S, Goulet R Jr (2011) Central venous port placement: a comparison of axillary versus anterior chest wall placement. Ann Surg Oncol 18:468-471
43. Platzbecker U, Illmer T, Schaich M, Freiberg-Richter J, Helwig A, Plettig R, Jenke A, Ehninger G, Bornhauser M (2001) Double lumen port access in patients receiving allogeneic blood stem cell transplantation. Bone Marrow Transplant 28:1067-1072 (Pubitemid 34030655)
44. Ponnet G, Goossens P, Oost C (1997) A comparative study between 3 venous access systems with various types of catheters. Oncologica 14:18-21
45. Poorter RL, Lauw FN, Bemelman WA, Bakker PJ, Taat CW, Veenhof CH (1996) Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 32A:2262-2266
46. Puig-La Calle J Jr, Lopez SS, Piedrafita SE, Allende HL, Artigas RV, Puig la CJ (1996) Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273-278 (Pubitemid 26262351)
47. Ramirez JM, Miguelena JM, Guemes A, Moncada E, Cabezali R, Sousa R (1993) Fully implantable venous access systems. Br J Surg 80:347-348 (Pubitemid 23091536)
48. Rubenstein EB, Fender A, Rolston KV, Elting LS, Prasco P, Palmer J, Road I, Pollock RE, Frisbee-Hume S, Laurence D (1995) Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. J Clin Oncol 13:1513-1519
49. Schutz JC, Patel AA, Clark TW, Solomon JA, Freiman DB, Tuite CM, Mondschein JI, Soulen MC, Shlansky-Goldberg RD, Stavropoulos SW, Kwak A, Chittams JL, Trerotola SO (2004) Relationship between chest port catheter tip position and port malfunction after interventional radiologic placement. J Vasc Interv Radiol 15:581-587 (Pubitemid 38758443)
50. Sehirali S, Inal MM, Ozsezgin S, Sanci M, Atli O, Nayki C, Yildirim Y, Tinar S (2005) A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy. Int J Gynecol Cancer 15:228-232 (Pubitemid 40396957)
51. Shetty PC, Mody MK, Kastan DJ, Sharma RP, Burke MW, Venugopal C, Burke TH (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991-995 (Pubitemid 27500436)
52. Silberzweig JE, Sacks D, Khorsandi AS, Bakal CW (2000) Reporting standards for central venous access. Technology assessment committee. J Vasc Interv Radiol 11:391-400 (Pubitemid 30161387)
53. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712-716 (Pubitemid 37267119)
54. Sonobe M, Chen F, Fujinaga T, Sato K, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H (2009) Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies. Int J Clin Oncol 14:208-212
55. Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospecive trial of conventional vascular ports vs.the vortex "clear-flow" reservoir port in adult oncology patients. JVAD 5(4):37-40
56. Surov A, Jordan K, Buerke M, Arnold D, John E, Spielmann RP, Behrmann C (2008) Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie 31: 455-461
57. Teichgraber UK, Streitparth F, Cho CH, Benter T, Gebauer B (2009) A comparison of clinical outcomes with regular-and low-profile totally implanted central venous port systems. Cardiovasc Interv Radiol 32:975-979
58. Vandoni RE, Guerra A, Sanna P, Bogen M, Cavalli F, Gertsch P (2009) Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 139:313-316
59. Vlasveld LT, Rodenhuis S, Rutgers EJ, Dubbelman AC, Hilton AM, Batchelor D, Rankin EM (1994) Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Oncol 20:122-129 (Pubitemid 24164465)
60. Wagner HJ, Teichgraber U, Gebauer B, Kalinowski M (2003) Transjugular implantation of venous port catheter systems. Rofo 175:1539-1544 (Pubitemid 37498489)
61. Wolosker N, Yazbek G, Nishinari K, Malavolta LC, Munia MA, Langer M, Zerati AE (2004) Totally implantable venous catheters for chemotherapy: experience in 500 patients. São Paulo Med J 122:147-151 (Pubitemid 39545238)